Eltrombopag is a hydrazine in which each nitrogen atom is substituted, one by a 3′-carboxy-2-hydroxy[1,1′-biphenyl]-3-yl group and the other by a 1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene group. A small molecule agonist of the c-mpl (TpoR) receptor (the physiological target of the hormone thrombopoietin), it has been developed as a medication for conditions that lead to thrombocytopenia (abnormally low platelet counts). Among its listed roles, it functions as a thrombopoietin receptor agonist and a xenobiotic. It belongs to the class of hydrazines, a member of pyrazoles and a member of benzoic acids. Its therapeutic use is listed as hematologic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Promacta and Revolade. Its PubChem CID is 135449332.
Eltrombopag
| CAS No | 496775-61-2 |
|---|---|
| Molecular Formula | C25H22N4O4 |
| Molecular Weight | 442.5 g/mol |
| Synonyms | 3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Eltrombopag is a hydrazine in which each nitrogen atom is substituted, one by a 3'-carboxy-2-hydroxy[1,1'-biphenyl]-3-yl group and the other by a 1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene group.
The listed CAS number is 496775-61-2.
The listed molecular formula is C25H22N4O4.
The listed molecular weight is 442.5 g/mol.
3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid.
The source lists Promacta and Revolade.